Please use this identifier to cite or link to this item:
|Title:||Deep proteomic profiling of human carotid atherosclerotic plaques using multidimensional LC-MS/MS||Authors:||Sze, Siu Kwan
Moll, Frans L.
de Kleijn, Dominique P. V.
|Keywords:||DRNTU::Science::Biological sciences::Human anatomy and physiology||Issue Date:||2014||Source:||Hao, P., Ren, Y., Pasterkamp, G., Moll, F. L., de Kleijn, D. P. V., & Sze, S. K. (2014). Deep proteomic profiling of human carotid atherosclerotic plaques using multidimensional LC-MS/MS. PROTEOMICS - clinical applications, 8(7-8), 631-635.||Series/Report no.:||PROTEOMICS - clinical applications||Abstract:||Purpose: To increase the proteome coverage of human atherosclerotic plaques and identify low-abundance proteins that may have important functions during the development and progression of atherosclerosis. Experimental design: Thirty-eight human carotid atherosclerotic plaques were pooled into two samples and analyzed in triplicate using offline multidimensional LC-MS/MS. The collected fractions of trypsin-digested peptides from Electrostatic Repulsion-Hydrophilic Interaction Chromatography (ERLIC) were analyzed by LC-MS/MS on a Q Exactive (Thermo Fisher, MA, USA). Results: A total of 4702 proteins were identified from atherosclerotic plaques at a false discovery rate (FDR) of 1%, of which 3846 were identified with at least 2 unique peptides. Many pathways related to the development and progression of atherosclerosis were identified, such as atherosclerosis signaling, toll receptor signaling pathway and inhibition of matrix metalloproteases. Many low-abundance proteins with important functions in atherosclerosis that were previously unidentifiable using mass spectrometry based proteomics methods, such as TGF-β, interleukins and other growth factors, were identified confidently from plaques. Conclusions and clinical relevance: This study has substantially increased the coverage of the atherosclerotic plaque proteome which represents a leap forward in understanding of plaque composition, development and progression. The identification of many low-abundance proteins may also facilitate biomarker discovery.||URI:||https://hdl.handle.net/10356/100610
|ISSN:||1862-8346||DOI:||10.1002/prca.201400007||Rights:||© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||SBS Journal Articles|
SCELSE Journal Articles
Updated on Mar 6, 2021
Updated on Mar 7, 2021
Page view(s) 10730
Updated on Aug 15, 2022
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.